Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Attovia Therapeutics, Inc. ATTO

Full chart Compare
Set alert

Price alert · ATTO

All alert types
16.81 USD +0.16 (+0.99%)

Nov 11, 2026, 10:10 AM EST

16.55 Day range 17.00
12.94 52-week range 28.00
YTD
-23.26%
1 year
-23.26%

Revenue & Expenses

Other Income → Expenses: $6.53MExpenses → Selling, General & Admin: $13.55MExpenses → Research & Development: $54.15MGross Profit → Expenses: $546.00KRevenue → Gross Profit: $546.00KRevenue → Cost of Revenue: $804.00KNet Loss → Expenses: $60.63MOther Income$6.53MGross Profit$546.00KNet Loss$60.63MCost of Revenue$804.00KExpenses$67.70MSelling, General & Admin$13.55MResearch & Development$54.15MRevenue$1.35M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
ATTO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
1.35M0
1.35M0
-67.16M-41.55M
-60.63M-39.80M
-15.42-12.76

Balance sheet

Full balance sheet How to read it
ATTO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
40.60M31.24M
165.89M76.72M
15.10M14.59M
5.26M0
-107.44M-46.83M

Cash flow

Full cash flow How to read it
ATTO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-59.20M-35.03M
-73.45M-39.80M
142.01M82.75M
-2.31M-1.77M
9.36M7.91M